Granules India Share Price Target 2025 to 2040, Detailed Analysis

By Suraj Sharma

Published on:

Granules India Share Price Target

Here, we are going to share Granules India Share Price Target 2025, 2026, 2027, 2028, 2030, 2035, 2040 on the basis of its fundamental and technical analysis.

Granules India Limited, founded in 1984 and headquartered in Hyderabad, is a famous Indian pharmaceutical firm that manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs).

The company has a strong global presence, selling products to over 300 clients in over 80 countries.

Granules India Share Key Information

Company NameGranules India Ltd
HeadquartersHyderabad
SectorsPharmaceuticals and Drugs
Market Cap₹ 12,940.07 Cr.
No. of Shares24.24Cr.
Book Value₹132.50
Dividend Yield0.28%
ROCE17.06%
ROE15.08%
Face Value₹1
Sales Growth-4.48%
Profit Growth-12.60%

Granules India Business Sector

  • APIs: Manufacturing bulk drugs like Paracetamol, Ibuprofen, Metformin, and Guaifenesin.
  • PFIs: Producing ready-to-compress granules, streamlining the manufacturing process for clients.
  • FDs: Offering finished dosage forms, including tablets and capsules, for direct consumption.

Board Members

  • Mr. Krishna Prasad Chigurupati: Chairman & Managing Director
  • Mr. Sandeep Neogi: Chief Financial Officer
  • Mr. GSR Prasad: Chief Operating Officer

Granules India Share Quarterly Results

PARTICULARSJun 2024 (Cr.)Sep 2024 (Cr.)
Net Sales 851.95567.99
Total Expenditure 674.54465.39
Operating Profit 177.42102.60
Other Income 1.812.78
Interest 17.5214.56
Depreciation 35.8534.75
Exceptional Items 00
Profit Before Tax 125.8656.07
Tax 32.0814.68
Profit After Tax 93.7841.39
Adjusted EPS (Rs) 3.871.71

Granules India Company Profits and Losses

PARTICULARSMar 2023 (Cr.)Mar 2024 (Cr.)
Net Sales 3,931.203,755.09
Total Expenditure 3,095.912,953.73
Operating Profit 835.29801.36
Other Income 12.885.78
Interest 38.6772
Depreciation 145.56143.85
Exceptional Items 00
Profit Before Tax 663.94591.29
Tax 165.16155.37
Net Profit 498.79435.92
Adjusted EPS (Rs.) 20.6117.99

Granules India Share Price Target 2025-2040

YearInitial TargetYear-End Target
2025₹567₹619
2026₹620₹670
2027₹672₹724
2028₹725₹776
2029₹777₹839
2030₹844₹911
2035₹1235₹1410
2040₹1690₹1960

Granules India Share Price Target 2025

Year/MonthPredicted Target
January 2025₹567
February 2025₹569
March 2025₹570
April 2025₹575
May 2025₹573
June 2025₹582
July 2025₹607
August 2025₹614
September 2025₹616
October 2025₹624
November 2025₹620
December 2025₹619

Based on the 2025 forecast, the initial target of Granules India share can could be ₹567 and by the end of the year, the share price target is estimated to reach ₹619.

Granules India Share Price Target 2026

Year/MonthPredicted Target
January 2026₹620
February 2026₹622
March 2026₹623
April 2026₹627
May 2026₹625
June 2026₹635
July 2026₹659
August 2026₹668
September 2026₹676
October 2026₹673
November 2026₹671
December 2026₹670

Based on the 2026 forecast, the initial target of Granules India share can could be ₹620 and by the end of the year, the share price target is estimated to reach ₹670.

Granules India Share Price Target 2027

Year/MonthPredicted Target
January 2027₹672
February 2027₹674
March 2027₹675
April 2027₹680
May 2027₹677
June 2027₹687
July 2027₹710
August 2027₹719
September 2027₹720
October 2027₹729
November 2027₹726
December 2027₹724

Based on the 2027 forecast, the initial target of Granules India share can could be ₹672 and by the end of the year, the share price target is estimated to reach ₹724.

Granules India Share Price Target 2028

Year/MonthPredicted Target
January 2028₹725
February 2028₹727
March 2028₹728
April 2028₹732
May 2028₹730
June 2028₹739
July 2028₹765
August 2028₹772
September 2028₹781
October 2028₹778
November 2028₹789
December 2028₹776

Based on the 2028 forecast, the initial target of Granules India share can could be ₹725 and by the end of the year, the share price target is estimated to reach ₹776.

Granules India Share Price Target 2029

Year/MonthPredicted Target
January 2029₹777
February 2029₹780
March 2029₹779
April 2029₹785
May 2029₹783
June 2029₹791
July 2029₹817
August 2029₹824
September 2029₹825
October 2029₹834
November 2029₹831
December 2029₹839

Based on the 2029 forecast, the initial target of Granules India share can could be ₹777 and by the end of the year, the share price target is estimated to reach ₹839.

Granules India Share Price Target 2030

Year/MonthPredicted Target
January 2030₹844
February 2030₹845
March 2030₹859
April 2030₹865
May 2030₹858
June 2030₹872
July 2030₹878
August 2030₹889
September 2030₹895
October 2030₹899
November 2030₹902
December 2030₹911

Based on the 2030 forecast, the initial target of Granules India share can could be ₹844 and by the end of the year, the share price target is estimated to reach ₹911.

Granules India Share Price Target 2035

Year/MonthPredicted Target
January 2035₹1235
April 2035₹1295
July 2035₹1340
October 2035₹1375
December 2035₹1410

Based on the 2035 forecast, the initial target of Granules India share can could be ₹1235 and by the end of the year, the share price target is estimated to reach ₹1410.

Granules India Share Price Target 2040

Year/MonthPredicted Target
January 2040₹1690
April 2040₹1740
July 2040₹1798
October 2040₹1850
December 2040₹1960

Based on the 2040 forecast, the initial target of Granules India share can could be ₹1690 and by the end of the year, the share price target is estimated to reach ₹1960.

Granules India Shareholding Pattern

TermsPercentage
Promoters38.87%
FIIs19.49%
DIIs14.85%
Others0%
Public26.80%

Granules India Company Competitors

  • Marksans Pharma
  • Shilpa Medicare
  • Blue Jet Healthcare
  • Glenmark Life Science
  • Sanofi India

Bull Case of Granules India (Reasons to Invest)

The company holds a 30% share of the global Paracetamol market, underscoring its significant industry position.

Granules India has received multiple ANDA approvals from the US FDA, facilitating the launch of new generic products in the U.S. market.

With ten manufacturing facilities and over 6,525 employees, the company demonstrates strong production capabilities and operational efficiency.

Bear Case of Granules India (Risks Involved)

The pharmaceutical industry faces pricing pressures due to increased competition, which could impact profit margins.

Compliance with stringent international regulations is critical; any lapses could lead to product recalls or bans.

The generic pharmaceutical sector is highly competitive, with numerous players vying for market share.

Granules India Share Price Target: FAQ

What will be the target of Granules India Share for the year 2025?

By the end of the year 2025, its share price can reach ₹619.

What will be the target of Granules India Share for the year 2026?

By the end of the year 2026, its share price can reach ₹670.

What will be the target of Granules India Share for the year 2027?

By the end of the year 2027, its share price can reach ₹724.

What will be the target of Granules India Share for the year 2028?

By the end of the year 2028, its share price can reach ₹776.

What will be the target of Granules India Share for the year 2029?

By the end of the year 2029, its share price can reach ₹839.

What will be the target of Granules India Share for the year 2030?

By the end of the year 2030 its share price can reach ₹911.

What is the Current market cap of Granules India company?

At present the market cap of this company is ₹ 12,940.07 Cr.

What is the NSE symbol of Granules India company?

The symbol of this company in NSE exchange is GRANULES.

What is the BSE symbol of Granules India company?

The symbol of this company in BSE exchange is 532482.

Read also:

Vedanta Share Price Target 2025 to 2040, Detailed Analysis

Canara Bank Share Price Target 2025 to 2040, Detailed Analysis

AMI Organics Share Price Target 2025 to 2040, Detailed Analysis

Suraj Sharma

SK Sharma is a senior content writer with 5 years of experience, having worked with top media outlets like Network 18 and Dainik Bhaskar. He holds a Post Graduate Diploma in English Journalism and currently writes full-time for Techiesk.

Leave a Comment